Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London · Delayed Price · Currency is GBP · Price in USD 37.49
-0.30 (-0.78%)
At close: Oct 24, 2025
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 3.95 billion as of October 24, 2025. Its market cap has increased by 132.98% in one year.
Market Cap
3.95B
Enterprise Value
3.81B
Revenue
418.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.49
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 3.95B, an increase of 21,905.91%. That is a compound annual growth rate of 28.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 3.95B | 111.32% |
| Dec 31, 2024 | 1.87B | -27.60% |
| Dec 29, 2023 | 2.58B | -27.67% |
| Dec 30, 2022 | 3.57B | -30.28% |
| Dec 31, 2021 | 5.12B | -11.38% |
| Dec 31, 2020 | 5.77B | 20.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.78B |
| GSK plc | 66.21B |
| Haleon | 31.28B |
| Smith & Nephew | 11.67B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 3.92B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.71B |